Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Japanese authorities approve denosumab for osteoporosis

March 27, 2013

Chugai gains Japanese approval for subcutaneous formulation of Actemra

March 27, 2013

Auxilium announces topline data from study of Xiaflex in frozen shoulder syndrome

March 27, 2013

Xeljanz obtains approval in Japan for rheumatoid arthritis

March 26, 2013

Biotest to begin phase IIb trial of tregalizumab in rheumatoid arthritis

March 26, 2013

Pluristem Therapeutics gives update on study of PLX cells in muscle injury

March 21, 2013

Novel tyrosine kinase inhibitors patented

March 20, 2013

Merck KGaA and Nordic Bioscience form alliance to develop treatment for osteoarthritis of the knee

March 18, 2013

Isis Pharmaceuticals reports phase I data for ISIS-CRPRx

March 14, 2013

Incyte Corp. prepares new series of JAK1 inhibitors

March 12, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...